Evidence map›Paper›PMID 40381614›Full record

ArticleNeuron2025

p16-expressing microglia and endothelial cells promote tauopathy and neurovascular abnormalities in PS19 mice.

Sara I Graves, Charlton F Meyer, Karthik B Jeganathan, Darren J Baker

Abstract read
In one paragraph

Article in Neuron, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Endothelial NADAlzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Entwined processes in Alzheimer's disease: Brain cellular senescence and Alzheimer's disease pathology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  15. Cerebrovascular p16Acta neuropathologica communications · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sara I GravesDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, 200 1st ST., Rochester, MN 55905, USA.
Charlton F MeyerDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, 200 1st ST., Rochester, MN 55905, USA.
Karthik B JeganathanDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, 200 1st ST., Rochester, MN 55905, USA.
Darren J BakerDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, 200 1st ST., Rochester, MN 55905, USA; Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 1st ST., Rochester, MN 55905, USA; Paul F. Glenn Center for Biology of Aging Research, Mayo Clinic, 200 1st ST., Rochester, MN 55905, USA; Robert and Arlene Kogod Center on Aging, Mayo Clinic, 200 1st ST., Rochester, MN 55905, USA. Electronic address: baker.darren@mayo.edu.

Funding

The contribution of p16-expressing cells to tauopathyR01AG053229 · NIA · MAYO CLINIC ROCHESTER · PI BAKER, DARREN · 2017 to 2021
$2.0M
Effects of senescence to Alzheimer's disease pathologyR01AG068076 · NIA · MAYO CLINIC ROCHESTER · PI BAKER, DARREN · 2020 to 2024
$2.0M
NIA NIH HHS R01 AG053229NIA NIH HHS R01 AG068076
6 · The paper itself

Abstract

Cellular senescence is characterized by irreversible cell-cycle exit, a pro-inflammatory secretory phenotype, macromolecular damage, and deregulated metabolism. Senescent cells are highly associated with age-related diseases. We previously demonstrated that targeted elimination of senescent cells prevents neurodegenerative disease in tau (MAPT

Indexed as

Cyclin-Dependent Kinase Inhibitor p16Endothelial CellsMicrogliaTauopathiesAnimalsBrainCellular SenescenceDisease Models, AnimalMaleMiceMice, Inbred C57BLMice, Transgenictau ProteinsCdkn2a protein, mouseCyclin-Dependent Kinase Inhibitor p16tau Proteinscellular senescenceendothelial cellsmicrogliamouse modelneurodegenerationp16(Ink4a)tauopathy

Identifiers

PMID40381614
PMCPMC12289416

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.